microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression

被引:62
作者
Tong, Shi-Jun [1 ]
Liu, Jun [1 ]
Wang, Xiang [1 ]
Qu, Lian-Xi [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Urol Surg, Shanghai 200040, Peoples R China
关键词
prostate cancer; cell proliferation; microRNA; miR-181; DAX-1; BIOMARKERS;
D O I
10.3892/etm.2014.1846
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
microRNAs (miRNAs) are a class of short noncoding RNA molecules that have a critical role in the initiation and progression of types of human cancer, including prostate cancer. In the present study, the expression of miR-181 in prostate Cancer tissues was evaluated and was demonstrated to be significantly upregulated in prostate cancer tissues compared with that in adjacent normal tissues. The results of in vitro MTT and BrdU incorporation assays, as well as cell-cycle analysis, indicated that miR-181 overexpression markedly promoted the proliferation of LNCaP cells. Furthermore, miR-181 overexpression was found to promote the progression of LNCaP tumor growth in nude mice. Mechanistic studies demonstrated that dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1), a negative regulator of androgen receptor in prostate cancer, was inhibited by miR-181 overexpression. Therefore, the results from the present study suggest that miR-181 functions as a growth-suppressive miRNA during prostate cancer development.
引用
收藏
页码:1296 / 1300
页数:5
相关论文
共 20 条
  • [1] Expression of Nuclear Receptor DAX-1 and Androgen Receptor in Human Breast Cancer
    Chae, Byung Joo
    Lee, Ahwon
    Bae, Ja Seong
    Song, Byung Joo
    Jung, Sang Seol
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (08) : 768 - 772
  • [2] El-Khairi R, 2011, ENDOCR DEV, V20, P38, DOI 10.1159/000321213
  • [3] The role of primary care in early detection and follow-up of cancer
    Emery, Jon D.
    Shaw, Katie
    Williams, Briony
    Mazza, Danielle
    Fallon-Ferguson, Julia
    Varlow, Megan
    Trevena, Lyndal J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (01) : 38 - 48
  • [4] Urinary biomarkers for prostate cancer: a review
    Hessels, Daphne
    Schalken, Jack A.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (03) : 333 - 339
  • [5] Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1
    Holter, E
    Kotaja, N
    Mäkela, S
    Strauss, L
    Kietz, S
    Jänne, OA
    Gustafsson, JÅ
    Palvimo, JJ
    Treuter, E
    [J]. MOLECULAR ENDOCRINOLOGY, 2002, 16 (03) : 515 - 528
  • [6] Hutchinson L, 2014, NAT REV CLIN ONCOL, V11, P61, DOI [10.1038/nrclinonc.2013.220, 10.1038/nrclinonc.2014.4, 10.1038/nrclinonc.2014.2, 10.1038/nrclinonc.2013.238]
  • [7] Hypogonadotropic hypogonadism in subjects with DAX1 mutations
    Jadhav, Unmesh
    Harris, Rebecca M.
    Jameson, J. Larry
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 346 (1-2) : 65 - 73
  • [8] Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
    Ji, Junfang
    Yamashita, Taro
    Budhu, Anuradha
    Forgues, Marshonna
    Jia, Hu-Liang
    Li, Cuiling
    Deng, Chuxia
    Wauthier, Elaine
    Reid, Lola M.
    Ye, Qing-Hai
    Qin, Lun-Xiu
    Yang, Wen
    Wang, Hong-Yang
    Tang, Zhao-You
    Groce, Carlo M.
    Wang, Xin Wei
    [J]. HEPATOLOGY, 2009, 50 (02) : 472 - 480
  • [9] MicroRNAs in prostate cancer
    Kim, Won Tae
    Kim, Wun-Jae
    [J]. PROSTATE INTERNATIONAL, 2013, 1 (01) : 3 - 9
  • [10] Targeting DAX-1 in embryonic stem cells and cancer
    Lalli, Enzo
    Alonso, Javier
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (02) : 169 - 177